Alberto Ascherio
Alberto Ascherio is a prominent epidemiologist at Harvard University, known for his research in the fields of infectious diseases and neurological disorders. His work has contributed significantly to understanding the links between viral infections and the development of conditions such as Alzheimer's disease. In a recent study regarding the effects of the herpes zoster vaccine on dementia risk, Ascherio expressed optimism about the findings, highlighting the need for further research to explore potential public health implications.
Not in the pool (under ¢1).
Recent news mentions
Alberto Ascherio lost US$7-million in federal research funding for his award-winning research, which seeks a cure to multiple sclerosis and other neurodegenerative diseases.
Trump’s funding cuts set back research on important health issues by years, Harvard scientists say
Canada· 2025-08-07
Alberto Ascherio is a professor of epidemiology and nutrition at the T.H. Chan School of Public Health at Harvard and the author of the study.
Un factor impensado puede aumentar el riesgo de sufrir enfermedad de Parkinson
Argentina· 2025-05-11
Alberto Ascherio was awarded the Breakthrough Prize for his significant contributions to the understanding of multiple sclerosis.
Descobertas sobre esclerose múltipla recompensadas com 'Óscar da Ciência'
Cabo Verde· 2025-04-06
Alberto Ascherio is a professor of Epidemiology at Harvard University who commented on the study's findings.
Un ensayo fortuito constata la eficacia de la vacuna del herpes frente a la demencia
Bolivia· 2025-04-03
Alberto Ascherio is a professor of Epidemiology at Harvard University who commented on the potential role of viral infections in Alzheimer's disease.
Vacuna del herpes sería efectiva contra la demencia - Ciencia
Paraguay· 2025-04-03Alberto Ascherio, a professor of epidemiology at Harvard University, describes the study as valuable and the most rigorous published on the topic.
Vacunarse contra el herpes zóster podría reducir el riesgo de sufrir demencia | Salud y bienestar
Spain· 2025-04-02